Jeffrey W. Runge - 01 Jun 2021 Form 4 Insider Report for Aditx Therapeutics, Inc. (ADTX)

Role
Director
Signature
/s/ Jeffrey W. Runge, M.D.
Issuer symbol
ADTX
Transactions as of
01 Jun 2021
Net transactions value
+$29,344
Form type
4
Filing time
02 Jun 2021, 17:38:47 UTC
Next filing
01 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADTX Common Stock Purchase $2,055 +700 +28% $2.94* 3,200 01 Jun 2021 Direct
transaction ADTX Common Stock Purchase $2,061 +700 +22% $2.94* 3,900 01 Jun 2021 Direct
transaction ADTX Common Stock Purchase $4,688 +1,600 +41% $2.93* 5,500 01 Jun 2021 Direct
transaction ADTX Common Stock Purchase $5,860 +2,000 +36% $2.93* 7,500 01 Jun 2021 Direct
transaction ADTX Common Stock Purchase $5,860 +2,000 +27% $2.93* 9,500 01 Jun 2021 Direct
transaction ADTX Common Stock Purchase $8,820 +3,000 +32% $2.94* 12,500 01 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.